01.03.2013 - Hikma Pharmaceuticals said it is reviewing options for its lucrative injectables business after receiving several unsolicited expressions of interest, driving up its shares nearly...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)